Lassen Therapeutics Presents Data Demonstrating Preclinical Anti-fibrotic Effect of LASN01, a Novel IL-11 Receptor-Blocking Antibody, at the American Thoracic Society 2022 Annual Meeting May 31, 2022
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies May 31, 2022
Colorescience Reveals Clinical Study Results of the Finishing Touch™ Skincare Protocol Following Facial Radiofrequency Microneedling Procedures May 27, 2022
Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights May 11, 2022
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones May 10, 2022
